Taken together, all these results demonstrate that one of the mechanisms through which melatonin can modulate aromatase enzyme in breast tumour cells is through its downregulatory action on the expression of COX enzymes, which decrease the levels of PGE2. The gene discussed is CYP19A1; the disease is breast neoplasm.